» Articles » PMID: 38397785

Increased Diabetes Complications in a Mouse Model of Oxidative Stress Due to 'Mismatched' Mitochondrial DNA

Overview
Date 2024 Feb 24
PMID 38397785
Authors
Affiliations
Soon will be listed here.
Abstract

Associations between chronic diabetes complications and mitochondrial dysfunction represent a subject of major importance, given the diabetes pandemic and high personal and socioeconomic costs of diabetes and its complications. Modelling diabetes complications in inbred laboratory animals is challenging due to incomplete recapitulation of human features, but offer mechanistic insights and preclinical testing. As mitochondrial-based oxidative stress is implicated in human diabetic complications, herein we evaluate diabetes in a unique mouse model that harbors a mitochondrial DNA from a divergent mouse species (the 'xenomitochondrial mouse'), which has mild mitochondrial dysfunction and increased oxidative stress. We use the streptozotocin-induced diabetes model with insulin supplementation, with 20-weeks diabetes. We compare C57BL/6 mice and the 'xenomitochondrial' mouse, with measures of heart and kidney function, histology, and skin oxidative stress markers. Compared to C57BL/6 mice, the xenomitochondrial mouse has increased diabetic heart and kidney damage, with cardiac dysfunction, and increased cardiac and renal fibrosis. Our results show that mitochondrial oxidative stress consequent to divergent mtDNA can worsen diabetes complications. This has implications for novel therapeutics to counter diabetes complications, and for genetic studies of risk, as mtDNA genotypes may contribute to clinical outcomes.

References
1.
Schiller N, Shah P, Crawford M, DeMaria A, Devereux R, FEIGENBAUM H . Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989; 2(5):358-67. DOI: 10.1016/s0894-7317(89)80014-8. View

2.
Jia G, Hill M, Sowers J . Diabetic Cardiomyopathy: An Update of Mechanisms Contributing to This Clinical Entity. Circ Res. 2018; 122(4):624-638. PMC: 5819359. DOI: 10.1161/CIRCRESAHA.117.311586. View

3.
McKenzie M, Trounce I, Cassar C, Pinkert C . Production of homoplasmic xenomitochondrial mice. Proc Natl Acad Sci U S A. 2004; 101(6):1685-90. PMC: 341818. DOI: 10.1073/pnas.0303184101. View

4.
Feder J, Blech I, Ovadia O, Amar S, Wainstein J, Raz I . Differences in mtDNA haplogroup distribution among 3 Jewish populations alter susceptibility to T2DM complications. BMC Genomics. 2008; 9:198. PMC: 2386827. DOI: 10.1186/1471-2164-9-198. View

5.
Nagisa Y, Kato K, Watanabe K, Murakoshi H, Odaka H, Yoshikawa K . Changes in glycated haemoglobin levels in diabetic rats measured with an automatic affinity HPLC. Clin Exp Pharmacol Physiol. 2003; 30(10):752-8. DOI: 10.1046/j.1440-1681.2003.03902.x. View